These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 29256375)
1. Using Telemetry Data to Refine Endpoints for New Zealand White Rabbits Challenged with Dawson DG; Bower KA; Burnette CN; Holt RK; Swearengen JR; Dabisch PA; Scorpio A J Am Assoc Lab Anim Sci; 2017 Nov; 56(6):792-801. PubMed ID: 29256375 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment. Comer JE; Ray BD; Henning LN; Stark GV; Barnewall RE; Mott JM; Meister GT Clin Vaccine Immunol; 2012 Sep; 19(9):1517-25. PubMed ID: 22837095 [TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469 [TBL] [Abstract][Full Text] [Related]
4. Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits. Yee SB; Dyer DN; Twenhafel NA; Pitt ML Comp Med; 2013 Jun; 63(3):252-61. PubMed ID: 23759528 [TBL] [Abstract][Full Text] [Related]
5. Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model. Chand HS; Drysdale M; Lovchik J; Koehler TM; Lipscomb MF; Lyons CR Infect Immun; 2009 Jan; 77(1):429-35. PubMed ID: 18981254 [TBL] [Abstract][Full Text] [Related]
6. Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment. Yee SB; Hatkin JM; Dyer DN; Orr SA; Pitt ML Comp Med; 2010 Dec; 60(6):461-8. PubMed ID: 21262133 [TBL] [Abstract][Full Text] [Related]
7. An integrated experimental-computational approach for predicting virulence in New Zealand white rabbits and humans following inhalation exposure to Bacillus anthracis spores. Hess BM; Thomas DG; Weber TJ; Hutchison JR; Straub TM; Bruckner-Lea CJ; Powell JD; Kabilan S; Corley RA PLoS One; 2019; 14(7):e0219160. PubMed ID: 31260462 [TBL] [Abstract][Full Text] [Related]
8. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302 [TBL] [Abstract][Full Text] [Related]
9. The physiologic responses of Dutch belted rabbits infected with inhalational anthrax. Lawrence WS; Hardcastle JM; Brining DL; Weaver LE; Ponce C; Whorton EB; Peterson JW Comp Med; 2009 Jun; 59(3):257-65. PubMed ID: 19619416 [TBL] [Abstract][Full Text] [Related]
10. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge. Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918 [TBL] [Abstract][Full Text] [Related]
11. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Zaucha GM; Pitt LM; Estep J; Ivins BE; Friedlander AM Arch Pathol Lab Med; 1998 Nov; 122(11):982-92. PubMed ID: 9822127 [TBL] [Abstract][Full Text] [Related]